Eli Lilly and Company Fourth Quarter Profit Jumps 28% on Better Revenue, Margins
(Reuters) - Eli Lilly and Co (LLY.N) reported better-than-expected fourth-quarter sales and earnings, bolstered by favorable taxes and strong sales of its Cymbalta depression medicine.